GO:1904627 response to phorbol 13-acetate 12-mystate: Signaling Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904627 describes any cellular or organismal process that changes in response to phorbol 13-acetate 12-myristate (PMA, also known as TPA), a potent diacylglycerol mimic and protein kinase C activator.
• PMA is widely used to differentiate monocytic cell lines such as THP-1 and U937 into macrophage-like cells, a model central to immunology and inflammation research.
• The response to PMA involves rapid activation of protein kinase C (PKC) isoenzymes, followed by downstream changes in gene expression, cytokine secretion, and cell morphology.
• PMA-induced differentiation protocols vary significantly, and the choice of protocol (concentration, duration, resting time) strongly influences experimental outcomes and macrophage responsiveness.
• PMA triggers complex signaling crosstalk, including HIF-1α and NF-κB pathways, which can be modulated by natural compounds such as tangeretin.
• Studying GO:1904627 requires integrated approaches including transcriptomics, proteomics, and CRISPR-based gene editing to dissect causal mechanisms.
Description
The Gene Ontology term GO:1904627, response to phorbol 13-acetate 12-myristate, defines the cellular and organismal processes that are altered following exposure to phorbol 13-acetate 12-myristate (PMA), also known as 12-O-tetradecanoylphorbol-13-acetate (TPA). PMA is a phorbol ester that acts as a potent tumor promoter and a functional analog of diacylglycerol, directly activating classical and novel protein kinase C (PKC) isoforms. Because of its ability to acutely stimulate PKC-dependent signaling, PMA is one of the most widely used pharmacological tools to study signal transduction, cell differentiation, and inflammatory responses in vitro and in vivo. The term encompasses a broad range of downstream effects, including changes in gene expression, enzyme production, secretion, and cell movement, as outlined in the QuickGO definition. For researchers, GO:1904627 is particularly relevant because PMA treatment is a standard method to differentiate human monocytic cell lines such as THP-1 and U937 into macrophage-like cells, which are then used to model innate immune responses, inflammasome activation, and host-pathogen interactions. The choice of PMA differentiation protocol, including concentration, exposure time, and resting period, can significantly affect the resulting macrophage phenotype and their response to subsequent pro-inflammatory stimuli. Moreover, PMA is used to study PKC-mediated signaling in diverse contexts, from myoblast biology to neurodevelopment and cancer. Understanding the full scope of the response to PMA is therefore essential for interpreting data from these widely used experimental systems and for identifying specific molecular players through genetic perturbation.
response to phorbol 13-acetate 12-myristate At A Glance
| GO ID | GO:1904627 |
|---|---|
| GO term | response to phorbol 13-acetate 12-myristate |
| Ontology | biological_process |
| Synonym | response to PMA; response to TPA; response to tetradecanoylphorbol acetate; response to phorbol 12-tetradecanoate 13-acetate |
| Major function | Mediates cellular responses to PMA, including PKC activation, differentiation, cytokine production, and changes in gene expression |
| Key cell types | Monocytes, macrophages, myoblasts, neurons, and various cancer cell lines |
| Common experimental models | THP-1 and U937 differentiation, rodent brain studies, in vitro kinase assays |
| Associated pathways | PKC signaling, NF-κB, HIF-1α, MAPK, and inflammasome activation |
What Is GO:1904627?
GO:1904627, response to phorbol 13-acetate 12-myristate, is a biological process defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phorbol 13-acetate 12-myristate stimulus. In simpler terms, it covers all the molecular and cellular events that occur when a cell or organism encounters PMA, a phorbol ester that mimics diacylglycerol and activates protein kinase C.
Why Is response to phorbol 13-acetate 12-myristate Important in Cell Biology?
GO:1904627 is critically important because PMA is one of the most widely used pharmacological agents to probe signal transduction, cell differentiation, and immune cell function. The response to PMA underpins the standard differentiation of THP-1 and U937 cells into macrophage-like models, which are ubiquitous in immunology and inflammation research. Moreover, PMA-induced PKC activation is a key experimental system for studying tumor promotion, cytokine regulation, and neurodevelopmental processes. Understanding the precise molecular events and genetic dependencies of this response is essential for reproducibility and for translating findings from cell models to human disease.
• PMA is the gold-standard agent for differentiating monocytic cell lines into macrophages, enabling studies of innate immunity and inflammation.
• The response to PMA involves activation of protein kinase C, a central node in many signaling pathways dysregulated in cancer.
• PMA-induced differentiation protocols vary, and standardization is critical for reproducible macrophage experiments.
• PMA modulates key transcription factors such as NF-κB and HIF-1α, linking it to hypoxia and inflammatory responses.
• PMA is used to study cytokine production, including Oncostatin-M, providing insights into immune regulation.
• The response to PMA can be studied in vivo, as shown by effects on the developing rodent brain.
• PMA is a classic tumor promoter, making it a tool for cancer biology and carcinogenesis research.
• Proteomic and transcriptomic analyses of PMA-treated cells reveal broad changes in immune-related proteins.
• CRISPR-based editing of genes involved in the PMA response can identify causal regulators of differentiation and inflammation.
• Understanding PMA responses helps interpret data from widely used cell models and improves experimental rigor.
What Happens During response to phorbol 13-acetate 12-myristate?
PMA Binding and PKC Activation
In simple terms: PMA acts like a key that turns on protein kinase C, a master switch for many cellular processes.
PMA binds to the C1 domain of classical and novel protein kinase C (PKC) isoforms, mimicking the endogenous lipid second messenger diacylglycerol. This binding leads to PKC activation and translocation to membranes, initiating phosphorylation cascades. Early studies demonstrated specific binding of PMA to cultured myoblasts, highlighting the direct interaction with cellular targets. This activation is the primary trigger for the downstream changes that define GO:1904627.
Downstream Signaling and Gene Expression
In simple terms: Once PKC is switched on, it sets off a chain reaction that changes which genes are turned on or off.
Activated PKC phosphorylates numerous substrates, leading to activation of transcription factors such as NF-κB and AP-1. This results in altered gene expression, including the induction of cytokines and other immune mediators. For example, PMA stimulation regulates the transcription of Oncostatin-M, a cytokine involved in inflammation and cell growth. These transcriptional changes are a core component of the response to PMA.
Cellular Differentiation and Morphological Changes
In simple terms: PMA can make immature cells grow up into specialized cells, like turning monocytes into macrophages.
In monocytic cell lines such as THP-1 and U937, PMA treatment induces differentiation into macrophage-like cells, characterized by adherence, changes in cell surface markers, and enhanced phagocytic capacity. The differentiation protocol, including PMA concentration and resting time after treatment, significantly influences the resulting phenotype and responsiveness to pro-inflammatory stimuli. This differentiation process is a well-studied example of the response to PMA.
Inflammatory and Stress Responses
In simple terms: PMA can trigger inflammation and stress responses in cells, which is useful for studying diseases.
PMA is a potent activator of the NLRP3 inflammasome in differentiated macrophages, leading to IL-1β secretion. It also induces oxidative stress and modulates HIF-1α and NF-κB crosstalk, as shown in studies where tangeretin abrogated these effects. In vivo, PMA exposure affects the developing rodent brain, indicating that the response can have organism-level consequences. These inflammatory and stress-related outcomes are integral to GO:1904627.
Key Genes Involved in GO:1904627 response to phorbol 13-acetate 12-myristate
The following genes and proteins are central to the response to phorbol 13-acetate 12-myristate, based on their roles in PKC signaling, differentiation, and inflammatory pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKCA | Classical PKC isoform activated by PMA; mediates phosphorylation cascades | Key mediator of PMA response; target for KO to block differentiation |
| PRKCB | Classical PKC isoform; involved in immune signaling | Studied in macrophage activation and cytokine production |
| PRKCD | Novel PKC isoform; regulates cell cycle and apoptosis | Potential target for modulating PMA-induced effects |
| NFKB1 | Transcription factor downstream of PKC; drives inflammatory gene expression | Central to PMA-induced cytokine production |
| RELA | NF-κB subunit; activated by PMA | Readout of PMA response; target for CRISPR KO |
| HIF1A | Hypoxia-inducible factor; crosstalk with NF-κB under PMA stimulation | Modulated by tangeretin in PMA toxicity models |
| NLRP3 | Inflammasome sensor; activated in PMA-differentiated macrophages | Key for studying inflammasome in THP-1 models |
| IL1B | Pro-inflammatory cytokine; secreted upon NLRP3 activation | Measured as endpoint of PMA-induced inflammasome |
| OSM | Oncostatin-M; cytokine regulated by PMA at transcriptional level | Model for PMA-induced gene regulation |
| FOS | AP-1 component; induced by PKC activation | Marker of PMA response; target for KO |
| JUN | AP-1 component; downstream of PKC | Studied in PMA-induced differentiation |
| MAPK1 | ERK2; kinase in MAPK pathway activated by PMA | Modulates differentiation and cytokine release |
| MAPK3 | ERK1; kinase in MAPK pathway | Involved in PMA-induced signaling |
| CD14 | Monocyte/macrophage marker; upregulated during PMA differentiation | Marker for successful THP-1 differentiation |
| ITGAM | CD11b; integrin upregulated in PMA-differentiated macrophages | Flow cytometry marker for differentiation |
| TNF | Tumor necrosis factor; cytokine induced by PMA | Readout of inflammatory response |
| IL6 | Interleukin-6; cytokine induced by PMA | Marker of PMA-induced inflammation |
| VDR | Vitamin D receptor; synergizes with PMA in U937 differentiation | Co-treatment studies for enhanced differentiation |
How Is response to phorbol 13-acetate 12-myristate Regulated?
The response to PMA is tightly regulated at multiple levels. PKC activity is controlled by phosphorylation, diacylglycerol levels, and subcellular localization. Downstream, transcription factors such as NF-κB and HIF-1α are subject to complex regulation, including negative feedback loops and crosstalk. The duration and concentration of PMA exposure, as well as the resting period after treatment, critically influence the differentiation state and subsequent responsiveness of cells, as shown in THP-1 macrophages. Additionally, natural compounds like tangeretin can modulate PMA-induced signaling by interfering with HIF-1α-NF-κB crosstalk. These regulatory mechanisms ensure that the cellular response to PMA is context-dependent and finely tuned.
response to phorbol 13-acetate 12-myristate and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Inflammasome-related autoinflammatory diseases | THP-1 KO of NLRP3 followed by PMA differentiation and inflammasome activation |
| HIF1A | Cancer, hypoxia, inflammation | CRISPR KO in cancer cell lines treated with PMA and tangeretin |
| NFKB1 | Inflammatory and immune disorders | Knockout in THP-1 or U937 cells to study PMA-induced cytokine production |
| PRKCA | Cancer, tumor promotion | Point mutation or KO to dissect PKC-dependent PMA responses |
| OSM | Inflammation, cancer | Overexpression or KO in PMA-treated cells to study cytokine regulation |
Cancer and Tumor Promotion
PMA is a classic tumor promoter, and the response to PMA is intimately linked to carcinogenesis through PKC activation and downstream oncogenic signaling. Dysregulated PKC isoforms are implicated in various cancers, and PMA is used experimentally to study tumor promotion and to identify chemopreventive agents. The crosstalk between HIF-1α and NF-κB under PMA stimulation further connects this response to hypoxia and inflammation in the tumor microenvironment.
Inflammatory and Autoimmune Diseases
PMA-induced differentiation of monocytes to macrophages is a cornerstone for modeling inflammatory diseases. The NLRP3 inflammasome, activated in PMA-differentiated THP-1 cells, is central to IL-1β-mediated pathologies such as gout, atherosclerosis, and autoinflammatory syndromes. PMA also regulates cytokines like Oncostatin-M and TNF, which are involved in chronic inflammation. Thus, understanding GO:1904627 aids in dissecting mechanisms of inflammatory disease and testing anti-inflammatory compounds.
Neurodevelopmental and Neurological Disorders
PMA affects the developing rodent brain, indicating that the response to PMA can influence neurodevelopmental processes. While the exact relevance to human neurological disorders requires further study, these findings suggest that PKC-mediated signaling pathways may play roles in brain development and injury responses.
From response to phorbol 13-acetate 12-myristate-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate PMA-induced macrophage differentiation? | CRISPR knockout of gene X in THP-1 cells followed by PMA treatment |
| Does a specific point mutation in PKC alter PMA response? | Knock-in of mutant PRKCA in cell lines, then PMA stimulation |
| Can a tagged version of a signaling protein track PMA-induced translocation? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of gene Y enhance PMA-induced cytokine production? | Overexpression of gene Y in THP-1 or U937 cells, then PMA treatment |
| What is the role of gene Z in PMA-induced inflammasome activation? | Knockout of gene Z in THP-1, differentiate with PMA, then NLRP3 activation |
| Does a natural compound modulate PMA response via gene W? | CRISPR KO of gene W in cells treated with PMA and compound |
How to Study the response to phorbol 13-acetate 12-myristate Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify PMA-induced transcripts in THP-1 cells |
| Proteomics | Protein abundance and modifications | Compare immune responses in PMA-differentiated macrophages |
| CRISPR KO | Loss-of-function effects | Test if a gene is required for PMA-induced differentiation |
| CRISPR knock-in | Tagged protein localization or mutant expression | Track PKC translocation or mutant function |
| Flow cytometry | Cell surface marker expression | Quantify CD14/CD11b upregulation after PMA |
| Western blot | Protein phosphorylation and expression | Measure PKC activation and downstream targets |
| ELISA | Cytokine secretion | Measure IL-1β, TNF, or OSM after PMA treatment |
| Microscopy | Cell morphology and adherence | Assess macrophage differentiation |
Transcriptomic Profiling (RNA-seq)
RNA sequencing of cells treated with PMA can reveal global changes in gene expression that define the response. This method has been used to identify PMA-regulated genes such as Oncostatin-M and to compare differentiation protocols. It is essential for understanding the transcriptional landscape of GO:1904627.
Proteomic Analysis
Mass spectrometry-based proteomics of PMA-treated cells, such as THP-1 macrophages, can quantify changes in protein abundance and post-translational modifications. Comparative proteomic analysis has revealed varying impacts on immune responses during PMA-mediated differentiation. This approach identifies effector proteins and pathways.
CRISPR-Cas9 Gene Editing
CRISPR knockout, knock-in, or point mutation of candidate genes in cell models (e.g., THP-1, U937) allows causal testing of their role in the PMA response. For example, knocking out NLRP3 can assess its requirement for inflammasome activation after PMA differentiation. This method is powerful for dissecting the genetic basis of GO:1904627.
Imaging and Flow Cytometry
Fluorescence microscopy and flow cytometry can track morphological changes, marker expression (e.g., CD14, CD11b), and protein translocation (e.g., PKC-GFP) during PMA treatment. These methods provide spatial and quantitative readouts of the response.
How CRISPR Can Be Used to Study GO:1904627 response to phorbol 13-acetate 12-myristate
Knockout
CRISPR knockout of genes such as NLRP3, NFKB1, or PRKCA in THP-1 or U937 cells can determine their necessity in the response to PMA. For instance, NLRP3 knockout followed by PMA differentiation and inflammasome activation reveals its role in IL-1β secretion. This approach provides causal evidence for gene function in GO:1904627.
Point Mutation
Introducing specific point mutations in genes like PRKCA can dissect domain functions or phosphorylation sites critical for PMA response. For example, mutating the C1 domain can abolish PMA binding and downstream signaling. Such models help map structure-function relationships.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at endogenous loci allows real-time tracking of protein localization during PMA treatment. Tagging PKC isoforms can visualize translocation to membranes upon PMA stimulation. This provides dynamic insights into the response.
Overexpression
Overexpression of candidate genes, such as OSM or HIF1A, in cell lines can test gain-of-function effects on PMA-induced phenotypes. For example, overexpressing HIF-1α may enhance PMA-induced inflammatory responses. This complements loss-of-function studies.
How EDITGENE Supports response to phorbol 13-acetate 12-myristate Research
Researchers studying response to phorbol 13-acetate 12-myristate-related genes often need to determine whether a candidate gene is causally involved in differentiation, cytokine production, or inflammasome activation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous testing of gene function in the context of PMA response.
Contact EDITGENE today to design your custom CRISPR model for response to phorbol 13-acetate 12-myristate research.
Frequently Asked Questions About response to phorbol 13-acetate 12-myristate
What is GO:1904627?
GO:1904627 is the Gene Ontology term for response to phorbol 13-acetate 12-myristate, describing any cellular or organismal change triggered by PMA, a PKC activator.
What is phorbol 13-acetate 12-myristate (PMA)?
PMA, also known as TPA, is a phorbol ester that mimics diacylglycerol and potently activates protein kinase C, widely used to differentiate monocytes into macrophages.
What genes are involved in the response to PMA?
Key genes include PRKCA, PRKCB, NFKB1, RELA, HIF1A, NLRP3, IL1B, OSM, FOS, JUN, and MAPK1/3, among others.
How is PMA used to differentiate THP-1 cells?
THP-1 monocytes are treated with PMA (typically 10-100 nM) for 24-72 hours, followed by a resting period, to become adherent macrophage-like cells.
What is the role of PKC in the PMA response?
PMA directly binds and activates classical and novel PKC isoforms, initiating phosphorylation cascades that alter gene expression and cell behavior.
Does PMA induce inflammation?
Yes, PMA activates NF-κB and the NLRP3 inflammasome, leading to secretion of pro-inflammatory cytokines such as IL-1β and TNF.
What diseases are linked to the PMA response?
The response is linked to cancer, inflammatory diseases, and neurodevelopmental processes through PKC, NF-κB, and HIF-1α signaling.
How can CRISPR be used to study the PMA response?
CRISPR knockout, knock-in, or point mutation of candidate genes in cell models can determine their causal role in PMA-induced differentiation and inflammation.
What methods are used to study GO:1904627?
Common methods include RNA-seq, proteomics, flow cytometry, ELISA, Western blot, and imaging, often combined with CRISPR editing.
Why is the PMA differentiation protocol important?
Variations in PMA concentration, exposure time, and resting period significantly affect macrophage phenotype and experimental reproducibility.
Conclusion
GO:1904627, response to phorbol 13-acetate 12-myristate, encompasses a broad and biologically significant set of processes triggered by PMA, a widely used PKC activator. From monocyte-to-macrophage differentiation to inflammatory cytokine production and inflammasome activation, this response is central to immunology, cancer biology, and neurobiology research. Understanding the genetic and molecular players involved is essential for interpreting data from common cell models and for developing targeted interventions. With CRISPR-based tools from EDITGENE, researchers can precisely dissect the causal roles of specific genes in this response, advancing both basic science and therapeutic discovery.
References
- 1. Lund ME et al.. 2016. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus.. J Immunol Methods 430:64-70 PMID: 26826276
- 2. Giambelluca S et al.. 2022. Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome.. Front Immunol 13:958098 PMID: 36618426
- 3. Valdés López JF et al.. 2018. Synergism between phorbol-12-myristate-13-acetate and vitamin D3 in the differentiation of U937 cells to monocytes and macrophages.. Morphologie 102(338):205-218 PMID: 30075941
- 4. Schimmel SD et al.. 1980. Binding of phorbol-12-myristate-13-acetate to cultured myoblasts.. Cancer Lett 9(3):229-36 PMID: 7226155
- 5. Mukherjee S et al.. 2016. Phorbol-12-myristate-13-acetate (PMA) mediated transcriptional regulation of Oncostatin-M.. Cytokine 88:209-213 PMID: 27676154
- 6. Dzietko M et al.. 2015. Effects of PMA (PHORBOL-12-MYRISTATE-13-ACETATE) on the Developing Rodent Brain.. Biomed Res Int 2015:318306 PMID: 25918710
- 7. Chang SN et al.. 2020. Phorbol 12-Myristate 13-Acetate Induced Toxicity Study and the Role of Tangeretin in Abrogating HIF-1α-NF-κB Crosstalk In Vitro and In Vivo.. Int J Mol Sci 21(23) PMID: 33291656
- 8. Pinto SM et al.. 2021. Comparative Proteomic Analysis Reveals Varying Impact on Immune Responses in Phorbol 12-Myristate-13-Acetate-Mediated THP-1 Monocyte-to-Macrophage Differentiation.. Front Immunol 12:679458 PMID: 34234780
